News for Apyx Medical Corp Stock (APYX)

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Apyx Medical Corporation (APYX)

Business Wire • 06/08/22

EQUITY ALERT: Rosen Law Firm Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – APYX

Business Wire • 06/08/22

APYX MEDICAL CORPORATION (APYX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Apyx Medical Corporation (APYX)

Newsfile Corp • 06/08/22

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of APYX Medical Corporation (APYX) Investors

Business Wire • 06/08/22

APYX MEDICAL CORPORATION (NASDAQ: APYX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation (NASDAQ: APYX)

PRNewsWire • 06/07/22

APYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm

Business Wire • 06/07/22

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Apyx Medical Corporation (APYX) Investors

Business Wire • 06/06/22

APYX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Apyx Medical Corporation

Business Wire • 06/06/22

Why Are Apyx Medical Shares Trading Higher Today?

Benzinga • 05/26/22

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures

Business Wire • 05/26/22

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June

Business Wire • 05/25/22

Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q1 2022 Results - Earnings Call Transcript

Seeking Alpha • 05/12/22

Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

Business Wire • 05/12/22

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Business Wire • 04/25/22

The Law Offices of Frank R. Cruz Continues Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Business Wire • 04/23/22

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Business Wire • 04/22/22

APYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corp. on Behalf of Apyx Stockholders and Encourages Investors to Contact the Firm

Business Wire • 04/22/22

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Business Wire • 04/21/22

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Business Wire • 04/20/22

The Law Offices of Frank R. Cruz Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Business Wire • 04/14/22

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022

Business Wire • 04/04/22

Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin

Business Wire • 04/04/22

Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q4 2021 Results - Earnings Call Transcript

Seeking Alpha • 03/17/22

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook

Business Wire • 03/17/22

Apyx Medical Corporation Notified of Pending FDA Medical Device Safety Communication Related to its Advanced Energy Products

Business Wire • 03/14/22

1
2
3
4
5

6
7
8
9